Compare Indonesia Pondasi Raya Tbk. (IDPR) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indonesia Pondasi Raya Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Indonesia Pondasi Raya Tbk. trades at Rp278 (market cap 540.81B, 680.7K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Indonesia Pondasi Raya Tbk. is far larger — about 5.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| IDPR | SCPI | |
|---|---|---|
Market Cap | 540.81B | 104.4B |
Volume | 680.7K | — |
Lot | 6.81K | — |
Turnover | 198.43M | — |
Average Price | 291.51 | — |
Value | 198.43M | — |
Indicative Equilibrium Price | 286 | — |
Indicative Equilibrium Volume | 10 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indonesia Pondasi Raya Tbk.
PT Indonesia Pondasi Raya Tbk (the Company) was established in Jakarta based on Notarial Deed Tan Thong Kie No. 18 dated 21 October 1977 and has been approved by the Ministry of Law in its decision letter No. Y.A 5/118/24 and was published in Supplement No. 430 of the State Gazette No. 49 dated 17 June 1980.
Read more on IDPR →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
